Update on antiphospholipid syndrome in children

Area of Science:

• Pediatric Hematology
• Immunology
• Vascular Biology

Background:

• Thrombotic events in children are uncommon, often linked to catheters, infections, surgery, or genetic issues.
• Increasing reports suggest children present with antiphospholipid syndrome features, meeting diagnostic criteria.
• Antiphospholipid antibodies in children are not always associated with high thrombotic event rates.

Purpose of the Study:

• To explore the occurrence and characteristics of antiphospholipid syndrome in pediatric populations.
• To understand the risk factors and clinical presentation of thrombosis in children with antiphospholipid antibodies.
• To discuss therapeutic strategies for pediatric antiphospholipid syndrome.

Main Methods:

• Review of case reports, case series, and registry data involving children with antiphospholipid syndrome features.
• Analysis of clinical features and diagnostic criteria fulfillment in pediatric cases.
• Comparison of thrombotic risk and clinical manifestations between pediatric and adult patients.

Main Results:

• Children with antiphospholipid syndrome may not exhibit the same high thrombotic rates as adults.
• Developmental differences in coagulation proteins and healthier vascular endothelium contribute to lower risk.
• Therapeutic approaches focus on risk identification, prevention, and short-term management.

Conclusions:

• Pediatric antiphospholipid syndrome is recognized but presents differently than in adults.
• Children's unique physiology influences their thrombotic risk and management strategies.
• Focus on preventive health and tailored, short-term treatments is crucial for pediatric cases.